Detalles de la búsqueda
1.
Multimodal Theranostic Nanoparticles for Necrosis Targeting, Fluorescence/SPECT Imaging, and Radiotherapy of Residual Tumors after Hepatocellular Carcinoma Ablation.
Mol Pharm;
21(4): 1729-1744, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38449426
2.
Thimerosal, a competitive thioredoxin reductase 1 (TrxR1) inhibitor discovered via high-throughput screening.
Biochem Biophys Res Commun;
650: 117-122, 2023 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36780763
3.
Feasibility of the novel vascular disrupting agent C118P for facilitating high-intensity focused ultrasound ablation of uterine fibroids.
Int J Hyperthermia;
40(1): 2185576, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36913972
4.
Development and characterization of a chick embryo chorioallantoic membrane (CAM) based platform for evaluation of vasoactive medications.
Microvasc Res;
142: 104372, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35483521
5.
Radioiodinated hypericin as a tracer for detection of acute myocardial infarction: SPECT-CT imaging in a swine model.
J Nucl Cardiol;
29(6): 3432-3439, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296972
6.
Imaging Cell Death: Focus on Early Evaluation of Tumor Response to Therapy.
Bioconjug Chem;
31(4): 1025-1051, 2020 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32150392
7.
Pictorial Imaging-Histopathology Correlation in a Rabbit with Hepatic VX2 Tumor Treated by Transarterial Vascular Disrupting Agent Administration.
Int J Med Sci;
17(15): 2269-2275, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32922191
8.
Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
J Cell Biochem;
120(8): 12473-12488, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30825232
9.
Rhein-based necrosis-avid MRI contrast agents for early evaluation of tumor response to microwave ablation therapy.
Magn Reson Med;
82(6): 2212-2224, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31418484
10.
Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry.
Exp Cell Res;
369(1): 80-89, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29750896
11.
The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI-microangiography-histopathology in rats.
Int J Cancer;
143(7): 1817-1828, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29707770
12.
Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis.
Anal Chem;
90(22): 13249-13256, 2018 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30379067
13.
First Evaluation of Radioiodinated Flavonoids as Necrosis-Avid Agents and Application in Early Assessment of Tumor Necrosis.
Mol Pharm;
15(1): 207-215, 2018 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29226682
14.
Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology.
Br J Cancer;
117(10): 1529-1536, 2017 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28910821
15.
Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium.
Anal Chem;
89(2): 1260-1266, 2017 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27981843
16.
Characterization of a rat orthotopic pancreatic head tumor model using three-dimensional and quantitative multi-parametric MRI.
NMR Biomed;
30(2)2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28008670
17.
Excretion and toxicity evaluation of 131I-Sennoside A as a necrosis-avid agent.
Xenobiotica;
47(11): 980-988, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27830982
18.
Editorial for "Tumor Stiffness Measurements on Magnetic Resonance Elastography for Single Nodular Hepatocellular Carcinomas Can Predict Tumor Recurrence after Hepatic Resection".
J Magn Reson Imaging;
53(2): 597-598, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32964630
19.
Synthesis and Preclinical Evaluation of Radioiodinated Hypericin Dicarboxylic Acid as a Necrosis Avid Agent in Rat Models of Induced Hepatic, Muscular, and Myocardial Necroses.
Mol Pharm;
13(1): 232-40, 2016 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26568406
20.
Synthesis and Evaluation of 131I-Skyrin as a Necrosis Avid Agent for Potential Targeted Radionuclide Therapy of Solid Tumors.
Mol Pharm;
13(1): 180-189, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26647005